Skip to main content
Clinical Trials/DRKS00023167
DRKS00023167
Suspended
Not Applicable

Clinical testing of a new, CE-certified joint mechanism (MUTARS® HD coupling C-O-M) for the implantation of a tumour or revision prosthesis in the area of the knee joint - MUTARS HD C-O-M

niversitätsklinikum Essen0 sites175 target enrollmentOctober 19, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Evaluation of a CE-certified coupling mechanism (MUTARS HD coupling C-O-M) in case of implantation of a tumor- or revision-prosthesis in the knee
Sponsor
niversitätsklinikum Essen
Enrollment
175
Status
Suspended
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Essen

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients for which a tumour prosthesis of the proximal tibia or the type MUTARS® total knee, as well as MUTARS® distal femur, needs to be implanted. Indication for tumorresection and reconstruction is also given within the sarcoma\-tumor\-conference.
  • 1\.Patients are included for which a replacement operation to a revision endoprosthesis type GenuX® MK or KRI or instead to the systems MUTARS® proximal tibia or MUTARS® femur is necessary due to failure (e.g. infection, loosening, perioperative fracture) of a previously implanted knee endoprosthesis.

Exclusion Criteria

  • Patients without any indication for implantation of tumor prosthesis (decision of tumor conference) in case of sarcoma or metastasis. Furthermore excluded are patients without any need to implant an axis\-guided prosthesis in case of revision surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials